PRICE T ROWE ASSOCIATES INC /MD/ - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 1 filers reported holding ATARA BIOTHERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$82
-33.9%
54,991
-28.2%
0.00%
Q2 2023$124
-43.1%
76,624
+2.3%
0.00%
Q1 2023$218
-18.4%
74,866
-8.0%
0.00%
Q4 2022$267
-99.9%
81,332
-24.0%
0.00%
Q3 2022$405,000
+17.7%
106,955
+142.4%
0.00%
Q2 2022$344,000
+29.3%
44,115
+53.8%
0.00%
Q1 2022$266,000
-25.1%
28,679
+27.5%
0.00%
Q4 2021$355,000
-42.1%
22,501
-34.3%
0.00%
Q3 2021$613,000
+15.9%
34,229
+0.6%
0.00%
Q2 2021$529,000
+26.3%
34,033
+16.7%
0.00%
Q1 2021$419,000
-26.0%
29,157
+1.1%
0.00%
Q4 2020$566,000
+196.3%
28,833
+95.9%
0.00%
Q3 2020$191,000
-96.4%
14,717
-94.5%
0.00%
-100.0%
Q2 2019$5,334,000
-92.3%
265,230
-84.9%
0.00%
-90.0%
Q1 2019$69,632,000
+12.9%
1,751,752
-1.3%
0.01%0.0%
Q4 2018$61,675,000
-15.6%
1,775,326
+0.5%
0.01%
-9.1%
Q3 2018$73,059,000
+16.1%
1,766,845
+3.2%
0.01%
+10.0%
Q2 2018$62,938,000
-4.7%
1,712,600
+1.2%
0.01%0.0%
Q1 2018$66,025,000
+10867.6%
1,692,953
+6228.1%
0.01%
Q2 2016$602,000
+172.4%
26,753
+130.5%
0.00%
Q1 2016$221,000
-27.8%
11,6040.0%0.00%
Q4 2015$306,000
-75.9%
11,604
-71.3%
0.00%
Q3 2015$1,270,00040,3990.00%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Antipodean Advisors LLC 1,000,000$1,480,0007.58%
Redmile Group, LLC 6,280,813$9,295,6030.44%
Arctis Global LLC 397,046$587,6280.32%
Baupost Group 9,773,616$14,4650.28%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 230,000$413,4000.24%
MAVERICK CAPITAL LTD 6,290,713$9,310,2550.21%
683 Capital Management, LLC 1,200,000$1,776,0000.14%
STALEY CAPITAL ADVISERS INC 1,000,000$1,480,0000.08%
WASATCH ADVISORS LP 8,399,229$12,430,8590.08%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 525,000$777,0000.07%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders